PL2694090T3 - Lek zawierający rekombinowane lektyny jemioły do leczenia czerniaka złośliwego - Google Patents
Lek zawierający rekombinowane lektyny jemioły do leczenia czerniaka złośliwegoInfo
- Publication number
- PL2694090T3 PL2694090T3 PL12720117T PL12720117T PL2694090T3 PL 2694090 T3 PL2694090 T3 PL 2694090T3 PL 12720117 T PL12720117 T PL 12720117T PL 12720117 T PL12720117 T PL 12720117T PL 2694090 T3 PL2694090 T3 PL 2694090T3
- Authority
- PL
- Poland
- Prior art keywords
- mistellectins
- malignant melanoma
- containing recombinant
- medicine containing
- treating malignant
- Prior art date
Links
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 201000001441 melanoma Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11161400A EP2508195A1 (de) | 2011-04-06 | 2011-04-06 | Arzneimittel enthaltend rekombinante Mistellektine zur Behandlung des malignen Melanoms |
| EP12720117.6A EP2694090B1 (de) | 2011-04-06 | 2012-04-10 | Arzneimittel enthaltend rekombinante mistellektine zur behandlung des malignen melanoms |
| PCT/EP2012/056479 WO2012136857A1 (de) | 2011-04-06 | 2012-04-10 | Arzneimittel enthaltend rekombinante mistellektine zur behandlung des malignen melanoms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2694090T3 true PL2694090T3 (pl) | 2019-08-30 |
Family
ID=44393740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12720117T PL2694090T3 (pl) | 2011-04-06 | 2012-04-10 | Lek zawierający rekombinowane lektyny jemioły do leczenia czerniaka złośliwego |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US20140080764A1 (pl) |
| EP (2) | EP2508195A1 (pl) |
| AU (1) | AU2012238523B2 (pl) |
| CA (1) | CA2832376C (pl) |
| DK (1) | DK2694090T3 (pl) |
| ES (1) | ES2722803T3 (pl) |
| PL (1) | PL2694090T3 (pl) |
| RU (1) | RU2639445C2 (pl) |
| TR (1) | TR201903484T4 (pl) |
| UA (1) | UA115307C2 (pl) |
| WO (1) | WO2012136857A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3205348A1 (de) | 2016-02-15 | 2017-08-16 | Melema Pharma GmbH | Arzneimittel enthaltend rekombinante mistellektine zur behandlung von hirntumoren |
| US20220339241A1 (en) * | 2019-07-09 | 2022-10-27 | Unichem Laboratories Ltd | Stable formulations of recombinant proteins |
| CA3177876A1 (en) | 2020-05-07 | 2021-11-11 | Dhananjay Sathe | Anti-cancer proteins |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4221836A1 (de) * | 1992-07-03 | 1994-01-05 | Gabius Hans Joachim Prof Dr | Das biochemisch aufgereinigte Mistel-Lektin (ML-1) als therapeutisch anwendbarer Immunmodulator |
| ATE170922T1 (de) * | 1995-06-26 | 1998-09-15 | Madaus Ag Koeln | Rekombinantes mistellektin (rml) |
| DE19752597A1 (de) * | 1997-11-27 | 1999-06-10 | Madaus Ag | Verwendung von Lektinzubereitungen bei der Bekämpfung von Harnblasenkarzinomen |
| DE19804210A1 (de) * | 1998-02-03 | 1999-08-12 | Biosyn Arzneimittel Gmbh | Rekombinante Mistellektine |
| ES2287353T3 (es) * | 2001-12-21 | 2007-12-16 | Viscum Ag | Procedimiento para la determinacion de la capacidad de respuesta de un individuo a la lectina de muerdago. |
-
2011
- 2011-04-06 EP EP11161400A patent/EP2508195A1/de not_active Withdrawn
-
2012
- 2012-04-10 US US14/009,961 patent/US20140080764A1/en not_active Abandoned
- 2012-04-10 AU AU2012238523A patent/AU2012238523B2/en active Active
- 2012-04-10 WO PCT/EP2012/056479 patent/WO2012136857A1/de active Application Filing
- 2012-04-10 RU RU2013149175A patent/RU2639445C2/ru active
- 2012-04-10 PL PL12720117T patent/PL2694090T3/pl unknown
- 2012-04-10 EP EP12720117.6A patent/EP2694090B1/de active Active
- 2012-04-10 CA CA2832376A patent/CA2832376C/en active Active
- 2012-04-10 DK DK12720117.6T patent/DK2694090T3/en active
- 2012-04-10 ES ES12720117T patent/ES2722803T3/es active Active
- 2012-04-10 TR TR2019/03484T patent/TR201903484T4/tr unknown
- 2012-10-04 UA UAA201312897A patent/UA115307C2/uk unknown
-
2016
- 2016-03-08 US US15/064,371 patent/US9981007B2/en active Active
-
2018
- 2018-04-26 US US15/963,905 patent/US20180243366A1/en not_active Abandoned
-
2021
- 2021-07-30 US US17/389,858 patent/US20210379143A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2694090A1 (de) | 2014-02-12 |
| AU2012238523A1 (en) | 2013-10-24 |
| US20160175391A1 (en) | 2016-06-23 |
| AU2012238523B2 (en) | 2017-05-25 |
| WO2012136857A1 (de) | 2012-10-11 |
| US20180243366A1 (en) | 2018-08-30 |
| RU2013149175A (ru) | 2015-05-20 |
| RU2639445C2 (ru) | 2017-12-21 |
| ES2722803T3 (es) | 2019-08-16 |
| US20210379143A1 (en) | 2021-12-09 |
| CA2832376C (en) | 2020-03-24 |
| TR201903484T4 (tr) | 2019-04-22 |
| US20140080764A1 (en) | 2014-03-20 |
| UA115307C2 (uk) | 2017-10-25 |
| DK2694090T3 (en) | 2019-04-15 |
| EP2508195A1 (de) | 2012-10-10 |
| US9981007B2 (en) | 2018-05-29 |
| EP2694090B1 (de) | 2019-01-16 |
| CA2832376A1 (en) | 2012-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2807180A4 (en) | PEPTIDE AGENTS USED IN ANTICANCER THERAPY | |
| HRP20160851T1 (hr) | Prediktori za liječenje karcinoma | |
| HK1212617A1 (zh) | 白癜風的治療 | |
| HK1185874A1 (zh) | 用於治療癌症的新的 -氨基- -羥基-苯甲酰胺 | |
| EP2884843A4 (en) | TRANSDERMAL ADMINISTRATION OF PRAMIPEXOL IN HEAVY HEADACHES | |
| GB2499286B (en) | Two-part cannula dressing | |
| ZA201400854B (en) | Grinding apparatus | |
| EP2823825A4 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER | |
| PL2667922T3 (pl) | Urządzenie osłaniające | |
| HRP20180875T1 (hr) | Kombinacijska terapija raka jajnika | |
| IL238606A0 (en) | CD44v6-derivative peptides for the treatment of cancer metastases | |
| PL2694090T3 (pl) | Lek zawierający rekombinowane lektyny jemioły do leczenia czerniaka złośliwego | |
| EP2905029A4 (en) | MEDICAMENT FOR INHIBITING MALIGNANT TUMOR METASTASIS | |
| PL2855475T3 (pl) | Alfa-karboliny do leczenia nowotworu | |
| PL2663318T3 (pl) | Kompozycja farmaceutyczna do leczenia raka | |
| GB201220901D0 (en) | CD44v6-derived peptides for treating pancreatic cancer | |
| GB201116328D0 (en) | Treatment for tumours | |
| GB201118482D0 (en) | Treating tumours | |
| AU2011039V (en) | DC6000 Dianella caerulea | |
| AU2011038V (en) | DC4000 Dianella caerulea | |
| AU2011037V (en) | DC2100 Dianella caerulea | |
| AU2011036V (en) | DC1000 Dianella caerulea | |
| AU343277S (en) | Cover for beauty treatment devices | |
| GB201220891D0 (en) | CD44v6-derived peptides for treating breast cancers | |
| GB201120096D0 (en) | Novel therapy |